Professor Flavia Indrio, President of the 10th International Congress on Probiotics, Prebiotics, and Postbiotics in Pediatrics, previews the key topics for the upcoming 2026 event in Lecce, April 16-18.
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Women with lower DI-GM scores showed a higher risk of infertility, highlighting the potential importance of gut microbiota diversity as a factor in female reproductive health.
Industry
Sponsored by
dsm-firmenich Italy successfully hosts its first exclusive event on biotics.
Xervyteg® marks a major advance in microbiome therapeutics, with potential to become the first approved microbiota therapy in Europe.
Industry, Video
Sponsored by
Carlo Sala, Sales Director EMEA & LATAM - Microbiome BU at Sacco System, discusses the company innovative probiotic strains, tailored manufacturing services, and commitment to R&D.
Fungal metabolites such as FF-C1 may offer a new therapeutic approach for treating MAFLD and related conditions.
Certain barriers on the skin prevent easy colonization of new strains and specific life stages, such as adolescence, may be crucial for successful probiotic interventions.
World Microbiome Day: celebrating the invisible allies transforming health, business, and the planet
With the theme “Microbiome 101: What You Need to Know”, this year's WMD makes a bold and timely move: bringing microbiome science back to basics, and straight into the hands…
Danone has announced the acquisition of The Akkermansia Company (TAC), significantly expanding its investment into gut health and next-generation biotic research.
